Insulet investors with over $100k losses can seek lead plaintiff role as August 31 deadline approaches
Executive summary: Rosen Law Firm notified investors that those with losses over $100,000 in Insulet (PODD) shares bought during the class period can seek appointment as lead plaintiff, with a filing deadline of August 31 2026. The choice of lead plaintiff influences the direction of the litigation, potential settlement size, and associated legal costs for Insulet.
Who is involved: Insulet Corporation, Rosen Law Firm, eligible investors (>$100k loss), and the United States District Court overseeing the case.
Likely next: Interested investors will submit motions by August 31; the court will evaluate and appoint a lead plaintiff, after which the case will proceed to discovery and possibly settlement discussions.
Rosen Law Firm issued a reminder that purchasers of Insulet Corporation stock between February 21 2025 and May 26 2026 who suffered losses exceeding $100,000 may petition to serve as lead plaintiff in the ongoing securities fraud class action. The deadline to file a motion is August 31 2026. The lawsuit stems from allegations of misleading statements about the company's manufacturing and product safety, following two Omnipod device recalls that triggered a sharp share price decline.
Timeline
- — Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit (PR Newswire)
- — Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD (PR Newswire)
- — SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD (PR Newswire)
Analysis — what this means
Likely next events
- August 31 2026: deadline for Insulet lead plaintiff motions
- September 21 2026: lead plaintiff deadline for Primoris Services and Microvast Holdings securities fraud cases
- September 30 2026: expected initial case management conference for the Insulet securities fraud action (contingent on lead plaintiff appointment)
Sectors affected
- medical devices (insulin delivery)
- industrial manufacturing and engineering services
- battery and energy storage technology
- ophthalmic pharmaceuticals
Regulatory implications
- Potential SEC enforcement actions if violations of §10(b) and Rule 10b-5 are proven
- Increased scrutiny of public disclosures regarding product safety and quality control
Historical parallels
- August 27 2026: Pomerantz Law Firm filed a class action against Insulet Corporation (PODD) over similar allegations
- August 27 2026: SueWallSt reminder highlighted a $90 per share decline following two Omnipod recalls
- August 20 2026: earlier shareholder alert noted a 16‑month pattern of manufacturing quality disclosures preceding the recalls
Key entities
Sources
- Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit — PR Newswire
- Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD — PR Newswire
- SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD — PR Newswire
Related cases
- Insulet faces a class‑action securities fraud lawsuit with a lead‑plaintiff deadline of August 31, 2026
- Pomerantz Law Firm files securities class action against Insulet Corporation alleging misleading statements about Omnipod product safety and manufacturing controls
- Rosen Law Firm alerts Insulet investors of a lead plaintiff opportunity in a pending securities fraud class action
- Insulet investors face an August 31 lead‑plaintiff deadline in a securities‑fraud class action after a >6% stock drop tied to safety‑misrepresentation claims
- Investors are invited to seek lead plaintiff role in a securities fraud class action against Insulet over alleged Omnipod safety misrepresentations